Overview

A Study to Assess ASP0598 Otic Solution Following Topical Application in the Ear in Subjects With Chronic Tympanic Membrane Perforation (CTMP)

Status:
Recruiting

Trial end date:
2023-02-28

Target enrollment:

Participant gender:

Summary

The primary purpose of this study is to evaluate the safety and tolerability of ASP0598 Otic Solution. This study will also evaluate the efficacy of ASP0598 otic solution.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Astellas Pharma Global Development, Inc.

Treatments:

Pharmaceutical Solutions